ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

March 22, 2002

In Brief: Brown Named Dean At Wisconsin, Carnone To Head Cancer Center With Rusch Retirement

June 30, 1978

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013